Philippe Aftimos - JoVE Visualize

Showing results (81-90 of 82) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 82 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER StudyKomal L Jhaveri, Elgene Lim, Rinath Jeselsohn, et al.

Cancer Discovery|June 29, 2021

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening InitiativePhilippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, et al.

Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 82 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER StudyKomal L Jhaveri, Elgene Lim, Rinath Jeselsohn, et al.

Cancer Discovery|June 29, 2021

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening InitiativePhilippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, et al.

Pageof 9